PMID: 7537814Dec 1, 1994Paper

Functional properties of a cloned 5-hydroxytryptamine ionotropic receptor subunit: comparison with native mouse receptors

The Journal of Physiology
N HussyK A Jones

Abstract

1. A comparative study of the whole-cell and single-channel properties of cloned and native mouse 5-hydroxytryptamine ionotropic receptors (5-HT3) was undertaken using mammalian cell lines expressing the cloned 5-HT3 receptor subunit A (5-HT3R-A), superior cervical ganglia (SCG) neurones and N1E-115 cells. 2. No pharmacological difference was found in the sensitivity to the agonists 5-HT and 2-methyl-5-HT, or to the antagonists d-tubocurare and 3-tropanyl-3,5-dichlorobenzoate (MDL-72222). 3. Current-voltage (I-V) relationships of whole-cell currents showed inward rectification in the three preparations. Rectification was stronger both in cells expressing the 5-HT3R-A subunit and in N1E-115 cells when compared with SCG neurones. 4. No clear openings could be resolved in 5-HT-activated currents in patches excised from cells expressing the 5-HT3R-A subunit or N1E-115 cells. Current fluctuation analysis of whole-cell and excised-patch records revealed a slope conductance of 0.4-0.6 pS in both preparations. Current-voltage relationships of these channels showed strong rectification that fully accounted for the whole-cell voltage dependence. 5. In contrast, single channels of about 10 pS were activated by 5-HT in patches excised from...Continue Reading

Citations

Aug 26, 1999·Neuropharmacology·N M Barnes, T Sharp
Jun 15, 2000·Journal of Neurochemistry·M C HannaE F Kirkness
Sep 21, 2010·Quarterly Reviews of Biophysics·Andrew J ThompsonSarah C R Lummis
Jan 10, 1998·British Journal of Pharmacology·S Fletcher, N M Barnes
May 23, 1998·The Journal of Physiology·A M BrownJ A Peters
Nov 2, 2002·The Journal of Physiology·Sterling N SudweeksJerrel L Yakel
Nov 12, 2009·Pharmacological Reports : PR·Sandra CombrinkHeinz Bönisch
Jan 17, 2013·Protein Expression and Purification·Jung-Hyun NaYeon Gyu Yu
Oct 15, 2011·Journal of Physiology, Paris·Cecilia Bouzat
Jul 14, 2010·Pharmacology & Therapeutics·Jutta WalstabBeate Niesler
Jun 15, 2007·Genes, Brain, and Behavior·C W HodgeS P Kelley
Feb 14, 2012·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Caroline NothdurfterDan Rujescu
Apr 19, 2013·British Journal of Pharmacology·Amy S NewmanNicholas M Barnes
Jan 12, 2013·Journal of Neurochemistry·Yukiko NakamuraShoichi Shimada
Sep 29, 2011·The Journal of General Physiology·Nicole K McKinnonMyles H Akabas
May 2, 2006·European Journal of Pharmacology·Thomas N JensenBjarke Ebert
Sep 13, 2008·Neuropharmacology·Amy S ButlerNicholas M Barnes
Aug 5, 2008·Neuropharmacology·Andrew J Thompson, Sarah C R Lummis
Dec 5, 2002·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·J J Galligan
Apr 1, 1996·British Journal of Pharmacology·A JenkinsW R Lieb
Nov 21, 2007·Pflügers Archiv : European journal of physiology·Nelson P BarreraJ Michael Edwardson
Aug 24, 2005·Proceedings of the National Academy of Sciences of the United States of America·Nelson P BarreraJ Michael Edwardson
Mar 5, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Caroline NothdurfterRainer Rupprecht
Mar 22, 2007·Expert Opinion on Therapeutic Targets·Andrew J Thompson, Sarah C R Lummis
May 1, 1996·Pflügers Archiv : European journal of physiology·M GlitschA Karschin
Mar 30, 2007·Molecular Pharmacology·Beate NieslerMichael Brüss

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.